These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26909265)

  • 21. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
    Pluijm G; Löwik C; Papapoulos S
    Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.
    Bogdanos J; Karamanolakis D; Tenta R; Tsintavis A; Milathianakis C; Mitsiades C; Koutsilieris M
    Endocr Relat Cancer; 2003 Jun; 10(2):279-89. PubMed ID: 12790789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease.
    Cox TR; Erler JT; Rumney RMH
    Calcif Tissue Int; 2018 Feb; 102(2):163-173. PubMed ID: 29098360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.
    Yang Z; Yue Z; Ma X; Xu Z
    Front Oncol; 2020; 10():293. PubMed ID: 32211326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular niches for disseminated tumour cells in bone.
    Kusumbe AP
    J Bone Oncol; 2016 Sep; 5(3):112-116. PubMed ID: 27761369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies.
    Wu X; Li F; Dang L; Liang C; Lu A; Zhang G
    Front Cell Dev Biol; 2020; 8():76. PubMed ID: 32117996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of macrophages in bone metastasis.
    Vasiliadou I; Holen I
    J Bone Oncol; 2013 Dec; 2(4):158-66. PubMed ID: 26909287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone, a Secondary Growth Site of Breast and Prostate Carcinomas: Role of Osteocytes.
    Maroni P; Bendinelli P
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour-derived miRNAs and bone metastasis.
    Croset M; Kan C; Clézardin P
    Bonekey Rep; 2015; 4():688. PubMed ID: 25987987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?
    von Moos R; Haynes I
    J Clin Med; 2013 Aug; 2(3):89-102. PubMed ID: 26237064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities.
    Byrne NM; Summers MA; McDonald MM
    JBMR Plus; 2019 Mar; 3(3):e10125. PubMed ID: 30918917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Cell Colonisation in the Bone Microenvironment.
    Kan C; Vargas G; Pape FL; Clézardin P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.
    Holen I; Nutter F; Wilkinson JM; Evans CA; Avgoustou P; Ottewell PD
    Clin Exp Metastasis; 2015 Oct; 32(7):689-702. PubMed ID: 26231669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Endosteal Niche in Breast Cancer Bone Metastasis.
    Haider MT; Smit DJ; Taipaleenmäki H
    Front Oncol; 2020; 10():335. PubMed ID: 32232008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.
    Chappard D; Bouvard B; Baslé MF; Legrand E; Audran M
    Morphologie; 2011 Jun; 95(309):65-75. PubMed ID: 21620753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Roles of Bone Marrow-Resident Cells as a Microenvironment for Bone Metastasis.
    Shiozawa Y
    Adv Exp Med Biol; 2020; 1226():57-72. PubMed ID: 32030676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine aspects of bone metastases.
    Hofbauer LC; Rachner TD; Coleman RE; Jakob F
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):500-12. PubMed ID: 24880565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.